A carregar...

S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells

Metastatic melanoma is one of the most aggressive and drug-resistant cancers with very poor overall survival. Circulating melanoma cells (CMCs) were first described in 1991. However, there is no general consensus on the clinical utility of CMC detection, largely due to conflicting results linked to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Cayrefourcq, Laure, De Roeck, Aurélie, Garcia, Caroline, Stoebner, Pierre-Emmanuel, Fichel, Fanny, Garima, Françoise, Perriard, Françoise, Daures, Jean-Pierre, Meunier, Laurent, Alix-Panabières, Catherine
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6678250/
https://ncbi.nlm.nih.gov/pubmed/31330795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8070755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!